Prostate-specific kallikrein
CA 2270291 A1 · Owner: Goli, Surya K. · Inventors: Goli, Surya K.; Bandman, Olga
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a human prostate-specific kallikrein (HPSK) and polynucleotides which identify and encode HPSK. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HPSK and a method for producing HPSK. The invention also provides for agonists, antibodies or antagonists specifically , binding HPSK and their use, in the prevention and treatment of diseases associated with expression of HPSK. Additionally the invention provides for , the use of antisense molecules to polynucleotides encoding HPSK for the treatment of diseases associated with the expression of HPSK. The invention also provides …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 31, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 31, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 31, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.